Sartorius Aktiengesellschaft (ETR:SRT)

Market Cap	14.92B -1.7%
Revenue (ttm)	3.54B +4.7%
Net Income	154.90M +84.4%
EPS	2.24 +84.2%
Shares Out	n/a
PE Ratio	96.29
Forward PE	38.68
Dividend	0.73 (0.38%)
Ex-Dividend Date	Mar 27, 2026

Volume	1,891
Average Volume	4,725
Open	191.20
Previous Close	190.20
Day's Range	189.60 - 192.60
52-Week Range	131.40 - 208.00
Beta	1.52
RSI	51.38
Earnings Date	Feb 3, 2026

About ETR:SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 14,042
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT

Financial Performance

In 2025, ETR:SRT's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.